2024 Inova Fairfax MGR (Enduring Material): Update in S. aureus Bacteremia
Topic:Update in S. aureus Bacteremia
Learning Objectives
- Advance education in basic scientific principles applicable to clinical situations.
- Disseminate information regarding disease prevention and public health.
- Improve understanding of psychosocial and legal issues as they apply to delivery of excellent patient care.
- Provide updates in medical diagnosis and treatment to improve patient outcome.
Speaker(s)
Vance Fowler, MD
has a financial relationship (Other) with Astra Zeneca;.
has a financial relationship (Other) with Karius;.
has a financial relationship (Consulting Fee) with Astra Zeneca, Basilea;.
has a financial relationship (Stock Options) with Valanbio;.
has a financial relationship (Other) with UpToDate;.
has a financial relationship (Other) with EDE;.
has a financial relationship (Consulting Fee) with Aridis, Armata;.
has a financial relationship (Consulting Fee) with GSK, Genentech;.
has a financial relationship (Other) with Contrafect;.
has a financial relationship (Other) with Merck;.
has a financial relationship (Consulting Fee) with Debiopharm;.
has a financial relationship (Patent) with Patent pending;.
has a financial relationship (Other) with Basilea;.
has a financial relationship (Other) with MedImmune;.
has a financial relationship (Consulting Fee) with Contrafect;.
has a financial relationship (Stock Options) with ArcBio;.
Accreditation Statement
The Inova Office of Continuing Medical Education is accredited by the Medical Society of Virginia to provide continuing medical education for physicians.
Credit Designation Statement
The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 1.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency an
Available Credit
- 1.00 AMA PRA Category 1 Credit™